Free tool
FAERS Monitor: Sutab
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 213135 or its brand name (Sutab, Magnesium Sulfate, Potassium Chloride, Sodium Sulfate). Reports on generic versions are filed under their own applications.
Reports
1,589
Serious
211
13% of reports
Hospitalization
42
Death reported
2
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- vomiting827
- nausea424
- drug ineffective141
- abdominal distension94
- headache94
- abdominal pain upper88
- pruritus66
- wrong technique in product usage process65
- abdominal pain63
- dizziness62
- tremor61
- chills56
- malaise56
- hypersensitivity51
- diarrhoea48
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 263 |
| 2022 | 438 |
| 2023 | 426 |
| 2024 | 46 |
| 2025 | 397 |
| 2026 | 16 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,570 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| vomitingSignal | 827 | 23.3 | 22.2 | 18,018 |
| abdominal distensionSignal | 94 | 11.9 | 9.8 | 934 |
| nauseaSignal | 424 | 7.1 | 6.5 | 2,299 |
| chillsSignal | 56 | 6.3 | 4.9 | 247 |
| abdominal pain upperSignal | 88 | 5.7 | 4.6 | 336 |
| tremorSignal | 61 | 4.9 | 3.8 | 185 |
| wrong technique in product usage processSignal | 65 | 4.2 | 3.3 | 160 |
| hypersensitivitySignal | 51 | 3.6 | 2.8 | 96 |
| abdominal painSignal | 63 | 3.6 | 2.8 | 116 |
| pruritusSignal | 66 | 2.3 | 1.8 | 47 |
| headache | 94 | 2.0 | 1.6 | 46 |
| malaise | 56 | 1.7 | 1.3 | 15 |
| dizziness | 62 | 1.6 | 1.3 | 15 |
| drug ineffective | 141 | 1.4 | 1.2 | 18 |
| diarrhoea | 48 | 1.0 | 0.7 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.